TTKHLTCARETTK Healthcare Limited

Pharma · Drug Manufacturers - General · NSE · as of 2026-07-20 (delayed ~30 min in market hours)

₹1,015.90

▲ 3.62%

Decent

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)1,397.50

P/E21.28

P/B1.25

PEG0.61

ROE %6.03

ROCE %1.60

Debt / Equity0.02

EPS46.48

Revenue Growth %14.50

Profit Growth %34.70

Dividend Yield %1.00

Promoter Holding %75.62

FII Holding %1.87

DII Holding %—

Beta0.26

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals


Bull Flag	LONG	64%	₹1,015.90	₹963.30	₹1,093.63	1.48

HOLDConviction 70%

The picture

• Profit growth: 34.7% YoY
• Debt/Equity: 0.02
• Promoter holding: 75.6%
• RSI: 72
• MACD: bullish
• Price vs EMA21: above
• Bull Flag signal (setup quality 64%)

Bull case

• Profit growth: 34.7% YoY
• Debt/Equity: 0.02
• Promoter holding: 75.6%
• RSI: 72

Bear case

• ROE: 6.0%
• ROCE: 1.6%
• Golden cross setup: SMA50 below SMA200
• Max drawdown (1y): 45%

Key risks

• Elevated volatility / drawdown profile — size positions accordingly
• ROE: 6.0%
• ROCE: 1.6%

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)

₹1,015.90

Stop Loss

₹912.45

risk 10.2%

Target 1 (1.5R)

₹1,171.08

+15.3%

Target 2 (3R)

₹1,326.26

+30.6%

Support (20d)

₹880.60

Resistance (52w)

₹1,364.79

Risk : Reward

1 : 1.5 → 1 : 3

risking ₹103.45/share

ATR (volatility)

₹41.38

avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹41.38). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental

Technical

Momentum

Risk (safety)

Peers — Pharma

About

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripe water name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.